Imaging of Hepatocellular Carcinomas

Dear Colleagues,

Currently, radiology imaging plays a pivotal role in diagnosis and patient follow-up in the oncology field. Imaging of hepatocellular carcinomas (HCC) encompasses all types of imaging modalities, including ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). All these techniques contribute to the detection and characterization of HCCs, especially in differential diagnosis for other benign hepatic tumors. An important part of HCC imaging concerns providing anatomical information for preoperative planning. Innovations such as radiomics, artificial intelligence, and quantitative imaging are perfectly integrated with radiology imaging, and scientific research in the oncology field is necessary to explore all the possibilities we need to improve our diagnostic accuracy in tumor diagnosis and characterization. More comprehensive tumor diagnosis will enable dedicated treatment options, such as immunotherapy or target therapy tailored to specific imaging characteristics, to reduce non-responder patients and improve survival.

The aim of this Special Issue is to provide an overview of current imaging of HCC. In particular, it will be focused on state-of-the-art and future developments in imaging of hepatic tumors, techniques for the depiction of early involvement, follow-up, risk stratification, and therapeutic response. We are inviting original research articles, reviews, and perspectives to address some of these challenges for the imaging of HCC.

Prof. Dr. Masakatsu Tsurusaki
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• computed tomography
• magnetic resonance imaging
• Gd-EOB-DTPA
• PET/CT
• LI-RADS
• therapeutic response assessment
• biomarkers
• radiomics
• machine learning/deep learning